MENU
+Compare
VIR
Stock ticker: NASDAQ
AS OF
Jul 11 closing price
Price
$5.65
Change
-$0.28 (-4.72%)
Capitalization
781.04M

VIR Vir Biotechnology Forecast, Technical & Fundamental Analysis

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases... Show more

VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VIR with price predictions
Jul 11, 2025

VIR in upward trend: price rose above 50-day moving average on July 02, 2025

VIR moved above its 50-day moving average on July 02, 2025 date and that indicates a change from a downward trend to an upward trend. In of 34 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 02, 2025. You may want to consider a long position or call options on VIR as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VIR just turned positive on July 02, 2025. Looking at past instances where VIR's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for VIR crossed bullishly above the 50-day moving average on July 08, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where VIR advanced for three days, in of 261 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 144 cases where VIR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for VIR moved out of overbought territory on July 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VIR broke above its upper Bollinger Band on July 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.748) is normal, around the industry mean (17.292). P/E Ratio (0.000) is within average values for comparable stocks, (58.926). VIR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.456). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (54.054) is also within normal values, averaging (272.270).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. VIR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VIR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VIR is expected to report earnings to fall 20.41% to -70 cents per share on July 31

Vir Biotechnology VIR Stock Earnings Reports
Q2'25
Est.
$-0.70
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.11
Q3'24
Missed
by $0.51
Q2'24
Missed
by $0.13
The last earnings report on May 07 showed earnings per share of -87 cents, missing the estimate of -87 cents. With 1.25M shares outstanding, the current market capitalization sits at 781.04M.
A.I. Advisor
published General Information

General Information

a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1800 Owens Street
Phone
+1 415 906-4324
Employees
587
Web
https://www.vir.bio
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DSPIX54.39-0.18
-0.33%
BNY Mellon Instl S&P 500 Stk Idx I
NSFGX11.86-0.04
-0.34%
Natixis Target Retirement 2035 N
LTFOX20.06-0.10
-0.50%
Lord Abbett Affiliated F3
NQVAX58.29-0.34
-0.58%
Nuveen Multi Cap Value A
HMCLX14.90-0.13
-0.86%
Harbor Mid Cap Institutional

VIR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with SANA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-4.72%
SANA - VIR
63%
Loosely correlated
+3.21%
AXON - VIR
47%
Loosely correlated
-0.46%
CPRX - VIR
45%
Loosely correlated
-0.18%
NRIX - VIR
41%
Loosely correlated
-1.82%
BEAM - VIR
40%
Loosely correlated
-3.95%
More